CADILA HEALTHCARE LIMITED is one of the leading pharmaceutical companies in India. It is the flagship of Zydus Cadila group.

With a commitment to create a healthier world, Zydus Cadila leverages its proven strengths in technology, product innovation and therapy management. This commitment also underlines the core belief of being dedicated to life in all its various aspects.
The strong foundation, management expertise and resources have helped the company to explore, innovate and seek new avenues of growth. Cadila Healthcare Limited (CHL) came into being after the group restructuring in 1995 under which the operations of the group were consolidated.
C.H.L. is among the top ten companies in the domestic pharmaceutical market . With the acquisition of German Remedies Ltd., Zydus Cadila will become the fourth largest pharmaceutical group in the domestic formulations market. This acquisition marks a prominent entry into three high growth segments -- women healthcare, respiratory and oncologicals.
C.H.L. has over 175 brands across segments of Anti-Infectives, Gastrointestinal, Cardiovascular, Pain Management, Biologicals, Vaccines and OTC, of which 6 belong to the top 300 India pharma brands.
Some of its popular brands in:
· Formulations include Ciprobid, Penegra, GRD, Amlodac etc.
· Bulk drugs include Loratadine, Famotidine, Omeprazole, Losartan and Amlodipine.
· OTC segment includes EverYuth and Sugar Free.
Following are the various business units and subsidiaries of this group:
Zydus Cadila -- the flagship division focusing on anti-infectives and pain management.
Zydus Alidac-- a speciality division, which focuses on gastrointestinal segment.
Zydus Medica -- a speciality division, which focuses on cardiovascular segment.
Zydus Biogen -- a speciality division, which focuses on biologicals.
Zydus Neurosciences -- a specialty division, therapy areas include anti-depressants, anti-convulsants, anti-psychotics and tranquilizers.
Zydus Vaccicare -- exclusively markets vaccines like Vac Typh and HB Vac.
Consumer Products Division -- markets nutritional, skin specialities and OTC products, which include EverYuth and Sugar Free.
Zydus Pathline -- manufactures and markets diagnostic reagents and instruments for the pathological laboratories, blood banks and hospitals.
Micro marketing Division -- focuses on generic drug marketing.
Phytosurge Division -- markets herbal remedies for cold and cough, liver disorders, respiratory tract disorders, GI tract disorders and other general disabilities.
Bulk Drugs -- a key strategic business unit of Zydus Cadila which manufactures a range of modern bulk actives in the therapeutic areas of anti-ulcerants, psycholeptic drugs, anti-depressants, quinolones, anti-diabetics, anti-histaminics etc.
Dialforhealth India Limited -- a 100% subsidiary which provides forward integration in the areas of distribution and ecommerce by setting up e-pharmacies.
Recon Healthcare Limited -- a 100% subsidiary whose main focus areas include cardiovascular and pain management.
An Export House recognized by the government of India, Zydus Cadila has an international presence in more than 40 countries across the globe.
The life force at Zydus Cadila is the dedication of its employees.
Zydus Cadila understands and respects the individual needs and provides them with a range of facilities to help them grow as professionals in various facets of life. Recognizing the fact that a happy workforce is a productive workforce, Zydus Cadila ensures the well being of all its members.
A fact underlined in its core belief says ‘We build People to build our Business.’